Selling stockholder sells 13.2M shares of Alignment Healthcare in underwritten offering via J.P. Morgan

Alignment Healthcare, Inc.

Selling Stockholder sold 13,167,733 shares of common stock via J.P. Morgan Securities LLC.
Offering closed March 4, 2026; company will not receive any proceeds from the sale.
Shares offered under automatically effective Registration Statement on Form S-3ASR filed March 2, 2026.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Alignment Healthcare, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC and the selling stockholder listed on Schedule II thereto (effective 2026-03-02).

Action: entry
Agreement: underwriting
Counterparty: J.P. Morgan Securities LLC and the selling stockholder listed on Schedule II thereto
Effective: 2026-03-02

Exact text from the filing

On March 2, 2026, Alignment Healthcare, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC (the “Underwriter”) and the selling stockholder listed on Schedule II thereto (the “Selling Stockholder”) with respect to an underwritten offering by the Selling Stockholder of 13,167,733 shares (the “Shares”) of the Company’s common stock

View on SEC.gov

336 material agreements filed in the last 30 days. Browse all material agreements →

Alignment Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-091486

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.